Elmar Kraus analyst DZ BANK

Currently, out of the existing stock ratings of Elmar Kraus - 3 which are a Hold (60%), 2 which are a Buy (40%)

Elmar Kraus

Work Performance Price Targets & Ratings Chart

Analyst Elmar Kraus works at DZ BANK and is covering the Healthcare sector with 10 price targets and ratings displayed on 4 stocks.

Elmar Kraus's average stock forecast success ratio is 83.33% with an average time for price targets to be met of 567 days.

Most recent stock forecast was given on GILD, Gilead Sciences at 09-Dec-2022.

Wall Street Analyst Elmar Kraus

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $53.09 (22.32%) receiving and performance score of 2.98.

Average potential price target upside

BIIB Biogen LLY Eli Lilly and Company AZN AstraZeneca PLC GILD Gilead Sciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

381

$128.14 (50.68%)

363

28 days ago

23/37 (62.16%)

$64.18 (23.27%)

274

Buy

357

$104.14 (41.18%)

354

1 months 4 days ago

39/53 (73.58%)

$34.83 (13.28%)

160

Buy

335

$82.14 (32.48%)

325

1 months 19 days ago

23/31 (74.19%)

$27.77 (9.80%)

138

Hold

294

$41.14 (16.27%)

311

1 months 25 days ago

20/22 (90.91%)

$18.45 (6.24%)

220

Buy

305

$52.14 (20.62%)

323

1 months 25 days ago

6/19 (31.58%)

$49.9 (19.74%)

232

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Elmar Kraus?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart